The Melanoma Nursing Initiative – Home › Forums › Targeted therapy › Dosing and administration › New BRAF/MEK inhibitors coming to market › Reply To: New BRAF/MEK inhibitors coming to market
July 31, 2018 at 8:55 am #4873
Expert NurseMollie Reed
This was such exciting news. We haven’t taken anyone off of their current BRAF/MEK therapy, but if they develop side effects, we will certainly consider transitioning them to another. Also, we will certainly consider this combo front line now depending upon the patient circumstances.